References
- Roth S, Newman E, Pelcovitz D, et al. Complex PTSD in victims exposed to sexual and physical abuse: results from the DSM-IV field trial for posttraumatic stress disorder. J Trauma Stress 1997; 10(4): 539–5
- Yehuda R, Kahana B, Schmeidler J, et al. Impact of cumulative lifetime trauma and recent stress on current posttraumatic stress disorder symptoms in Holocaust survivors. Am J Psychiatry 1995; 152(12): 1815–8
- Jacobs WJ, Dalenberg C. Subtle presentations of post-traumatic stress disorder: diagnostic issues. Psychiatr Clin North Am 1998; 21(4): 835–45
- Eriksson N-G, Lundin T. Early traumatic stress reactions among Swedish survivors on the m/s Estonia disaster. Br J Psychiatry 1996; 169(6): 713–6
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Assn, 1994: 424–9
- Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 2000; 283(14): 1837–44
- Grossman LS, Willer JK, Stovall JG, et al. Underdiagnosis of PTSD and substance use disorders in hospitalized female veterans. Psychiatr Serv 1997; 48(3): 393–5
- Kaplan HI, Sadock BJ. Serotonin-specific reuptake inhibitors. In: Kaplan HI, Sadock BJ, eds. Synopsis of psychiatry. 8th ed. Baltimore: Williams & Wilkins, 1998; 1083–92
- Reich J. Comorbid anxiety and depression and personality disorder: a possible stress-induced personality disorder syndrome. Psychiatr Ann 1999; 29(12):707–12
- Labbate LA. Sex and serotonin reuptake inhibitor antidepressants. Psychiatr Ann 1999; 29(10): 571–4
- Othmer E, Othmer JP, Othmer SC. Brain functions and psychiatric disorders. Psychiatr Clin North Am 1998; 21(3): 517–66
- Kaplan HI, Sadock BJ. Tricyclics and tetracyclics. In: Kaplan HI, Sadock BJ, eds, 8 pp 1100–8
- Viola J, Ditzler T, Batzer W, et al. Pharmacological management of post-traumatic stress disorder: clinical summary of a five-year retrospective study, 1990–1995. Mil Med 1997; 162(9): 616–9
- Dopheide JA, Stimmel GL, Yi DD. Focus on nefazodone: a serotonergic drug for major depression. Hosp Formul 1995; 30(4): 205–12
- Khouzam HR, Mahdasian JA, Donnelly NJ. Three psychiatric medications. Patient Care 1998; 32(15): 27–31
- De Mello MF. Mirtazapine effectiveness in a patient with refractory psychotic depression. Int J Psychiatry Clin Pract 1999; 3(2): 141–2
- Friedman MJ, Southwick SM. Towards pharmacotherapy for posttraumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. Philadelphia: Lippincott-Raven, 1995: 465–81
- Post RM, Weiss SR, Smith MA. Sensitization and kindling: implications for the evolving neural substrates of post-traumatic stress disorder. In: Friedman MJ et al, eds, pp 203–24 17
- Stahl SM. Antidepressants: the blue-chip psychotropic for the modern treatment of anxiety disorders. J Clin Psychiatry 1999; 60(6): 356–7
- Khouzam HR. Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine. Depress Anxiety 2000; 11: 80–2
- Clark RD, Calais LA, Quails C, et al. Cyproheptadine treatment of nightmares associated with posttraumatic stress disorder. (Letter) J Clin Psychopharmacol 1999; 19(5): 486–7
- Elie R, Ruther E, Farr I, et al. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. J Clin Psychiatry 1999; 60(8): 536–44
- Khouzam HR, Kissmeyer P. Antidepressant treatment, posttraumatic stress disorder, survivor guilt, and spiritual awakening. J Trauma Stress 1997; 10(4): 691–6